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RESEARCH NOTE
Use of tuberculin skin test 
for assessment of immune recovery 
among previously malnourished children 
in Ethiopia
Paluku Bahwere1,2* , Philip James1,3, Alemseged Abdissa4, Yesufe Getu5, Yilak Getnet5, Kate Sadler1 
and Tsinuel Girma6
Abstract 
Objective: To compare levels of immunity in children recovering from severe acute malnutrition (cases) against 
those of community controls (controls).
Results: At baseline children recovering from severe acute malnutrition had lower, mid upper arm circumference 
(122 mm for cases and 135 mm for controls; p < 0.001), weight-for-height Z-score (− 1.0 for cases and − 0.5 for 
controls; p < 0.001), weight-for-age Z-score (− 2.8 for cases and − 1.1 for controls; p < 0.001) and height/length-for-
age Z-score (− 3.6 for cases and − 1.4 for controls; p < 0.001), than controls. Age and gender matched community 
controls. At baseline, prevalence of a positive tuberculin skin test, assessed by cutaneous delayed-type hypersensitiv-
ity reaction skin test, was very low in both cases (3/93 = 3.2%) and controls (2/94 = 2.1%) and did not significantly 
increase at 6 months follow up (6/86 = 7.0% in cases and 3/84 = 3.4% in controls). The incidences of common 
childhood morbidities, namely fever, diarrhoea and cough, were 1.7–1.8 times higher among cases than controls. 
In conclusion, these results show that tuberculin skin test does not enable any conclusive statements regarding the 
immune status of patients following treatment for severe acute malnutrition. The increased incidence of infection in 
cases compared to controls suggests persistence of lower resistance to infection even after anthropometric recovery 
is achieved.
Keywords: Severe acute malnutrition, Immunity, Delayed-type hypersensitivity response, Tuberculin skin test, 
Morbidity, Tuberculin purified protein derivative, Community-based management of acute malnutrition
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Introduction
Globally, 5.8 million children younger than 5 years died in 
2015 and millions more are permanently disabled by the 
physical and mental effects of a poor dietary intake in the 
earliest months of life [1]. Approximately 2% of children 
living in low income countries suffer from severe acute 
malnutrition (SAM) [2]. SAM is believed to account for 
at least 4.4% of the global under-five death burden and 
6.0% of disability-adjusted life-years lost [1]. Despite the 
tremendous progress of recent years, Ethiopia remains 
one of the countries with the highest burden of SAM [3].
The rapid scale-up of the community-based manage-
ment of acute malnutrition (CMAM) approach in many 
high burden countries has enabled better treatment cov-
erage and has contributed to saving lives of millions of 
children with SAM [4–11]. However, several studies have 
reported that children who recovered from SAM remain 
at high risk of infections and death several months after 
exiting treatment programmes [12–19]. One hypothesis 
is that the anthropometric and clinical discharge criteria 
that are used in treatment programmes may have weak 
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correlation with optimal recovery of body functions 
including immunity.
In Ethiopia, children with SAM are discharged from 
CMAM as recovered when they have fulfilled the fol-
lowing criteria: weight gain of 20%, mid upper-arm cir-
cumference (MUAC)  >  11.0  cm, resolved oedema and 
clinically stable for 2 consecutive weeks [20]. Here we 
describe a study conducted in Jimma Zone, Eastern Ethi-
opia, using a tuberculin purified protein derivative (PPD) 
skin test to verify if children who reached these discharge 
criteria had also recovered their immune response. This 
paper presents the results and discusses the utility of the 
test for this purpose.
Main text
Methods
This research was a sub-study of a larger 12  months 
prospective cohort study conducted from Septem-
ber 2013 to January 2015. The main study aimed to 
describe the mortality, morbidity and nutritional sta-
tus profiles of children aged 6–59  months discharged 
as recovered from CMAM for SAM treatment. It 
enrolled 215 post-SAM cases (‘cases’) discharged as 
recovered from CMAM sites of Jimma area and 215 
non-wasted community controls (‘controls’) matched 
from the same village with the cases by age, sex, moth-
er’s education and roof material. The controls were 
apparently healthy children with no history of treat-
ment for acute malnutrition. Cases and controls were 
followed up concurrently at their homes each month, 
assessing nutritional status (weight, height, MUAC, 
bilateral pitting oedema) reported morbidity of the 
past 2 weeks (history of fever, diarrhoea or cough) and 
vital status (alive or dead).
The extent of immune system recovery was assessed 
using the difference in incidence of infectious diseases 
between cases and controls and by a cutaneous delayed-
type hypersensitivity reaction skin test (DTHR) at enrol-
ment and at the 6-month follow up. The DTHR was 
assessed using the Tuberculin skin test (TST) [21]. TST 
was chosen because of its practicality for community-
based surveys, its commercial availability, and its wide 
usage in DTHR response and immune diagnosis of tuber-
culosis infection [22–24]. We used Tuberculin PPD RT23 
(Statens Serum Institute, Copenhagen, Denmark). The 
tuberculin PPD was kept refrigerated and transported to 
the field on ice and avoiding light exposure. This main-
tained the temperature of the vials between 2 and 8  °C 
throughout. The DTHR tests were performed by trained 
research nurses. 0.1  mL (2 Tuberculin Units/0.1  mL) of 
antigen was injected into the intradermal space on the 
volar surface of the forearm, using a 27-gauge needle 
with the bevel up and at an angle of 5–15°. Adherence to 
the injection technique was confirmed by the apparition 
of a small wheal of 6–10 mm as the antigen was injected 
into the dermis and by the absence of bleeding. Read-
ing and classification of the DTHR response was based 
on the diameter of the induration measured 48–72  h 
after the antigen injection [25]. A TST was regarded as 
positive if the transversal diameter of skin induration 
was ≥ 10 mm. Children were classified as anergic if there 
was no induration.
Morbidity was assessed by caretaker face-to-face inter-
views using a 2-week recall approach and a pre-tested 
standardised questionnaire. Caretakers were asked if 
the child had experienced fever, diarrhoea, or persistent 
cough during 2 weeks preceding the interview. All socio-
demographic, nutrition, medical and household infor-
mation captured by the questionnaire followed the same 
methodology described in James et al. [26].
In absence of literature data allowing precise calcula-
tion of sample size, a convenience sample size of 100 
cases and 100 controls was used for this study. Propor-
tions and means were compared using Chi squared tests 
and unpaired Student t test, respectively. We generated 
incidence rate ratios to compare morbidity incidence 
between the cases and controls.
Results
Characteristics at enrolment
Ninety-three cases and 95 controls were included in the 
present sub-study. The two groups did not differ for most 
of the parameters checked except for orphan status, age 
of carers, number of children below 5 years of age in the 
household, proportion of food secure households and 
nutrition status (Table  1). At enrolment the nutritional 
status of cases, indicated by MUAC, weight-for-height 
Z-score, weight-for-age Z-score and height/length-
for age Z-score, were lower than that of the controls 
(Table 1).
Results of cell mediated immunity assessment
In both cases and controls, less than 5% of children had 
a positive tuberculin skin test (Table 2). The rate of posi-
tivity did not increase between baseline and 6  months 
after enrolment (Table  2). Four cases anergic at enrol-
ment had a positive TST test at 6-months while one who 
had an induration of 9.5 mm at enrolment was anergic at 
6 months follow up. For the majority of reactive children, 
the diameter of induration was larger at 6-month follow 
up than at enrolment (Fig. 1).
Results on incidence of reported common morbidities
The incidences of fever [12.45 per 100-child-months 
in cases and 7.25 per 100-child-months in controls; 
incidence rate ratio (IRR): 1.85 (1.33–2.20); p  <  0.001], 
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diarrhoea [11.90 per 100-child-months in cases and 6.70 
per 100-child-months in controls; IRR: 1.77 (1.37–2.29); 
p  <  0.001], and cough [12.42 per 100-child-months in 
cases and 6.94 per 100-child-months in controls; IRR: 
1.79 (1.37–2.29); p  <  0.001] were 1.7–1.8 times higher 
among cases than controls.
Table 1 Socio-demographic, medical, nutrition and household characteristics of participating children
SAM severe acute malnutrition, MUAC mid upper arm circumference, IQR interquartile range, WASH water, sanitation and hygiene
a Using 2006 world Health organisation multicentre child growth references
b Based on 24 h recall of breastfeeding, dietary diversity and meal frequency
c Summarised as recommended by WHO and UNICEF methodology [62]
d Generated using principal component analysis as described in [61]
Characteristics Post-SAM cases (n = 93) Community controls (n = 95) p value
n (%) Median (IQR) n (%) Median (IQR)
Socio-demographic characteristics
 Female 39 (41.9) 41 (43.2) 0.865
 Age (months) 15 (6; 48) 14 (7; 48) 0.309
Medical history
 Ever immunised 77 (82.8) 80 (84.2) 0.794
 Presence of BCG scar 54 (58.1) 65 (68.4) 0.326
 Recent vitamin A supplementation 86 (92.5) 87 (91.6) 0.821
 Recent deworming 52 (55.9) 44 (46.3) 0.188
 Utilises insecticide treated bed net 47 (50.5) 53 (55.8) 0.767
Nutrition status
 Mid upper arm circumference (mm) 122 (118; 131) 135 (130; 143) < 0.001
 Weight-for-age Z-scorea − 2.8 (− 3.6; − 2.2) − 1.1 (− 1.8; − 0.5) < 0.001
 Height-for-age Z-scorea − 3.6 (− 4.6; − 2.6) − 1.4 (− 2.4; -0.7) < 0.001
 Weight-for-height Z-scorea − 1.0 (− 1.9; − 0.4) − 0.5 (− 1.1; 0.2) < 0.001
 % severe  stuntinga 60 (65.2) 17 (18.1) < 0.001
Caregivers information
 Both parents alive 79 (85.9) 92 (96.8) 0.004
 Mother as principal caregiver 89 (95.7) 93 (97.9) 0.442
 Caregiver ever attended school 17 (18.3) 22 (23.2) 0.410
 Principal caregiver age (years) 26 (13; 60) 25 (18; 55) 0.034
 Caregiver MUAC (mm) 222 (182; 297) 229 (122; 267)
 Infant and child feeding  indexb 0.074
 Lowest category 2 (2.1) 4 (4.2)
 Middle category 42 (45.2) 28 (29.5)
 Highest category 49 (52.7) 63 (66.3)
Household characteristics
 Male headed household 88 (95.6) 92 (96.8) 0.668
 Household head attended school 30 (32.3) 34 (36.2) 0.573
 Household size 6 (2–22) 5 (2–12) 0.081
 Number children below 5 years 2 (1–2) 1 (1–2) 0.020
 Food secure 50 (56.2) 77 (82.8) 0.001
 WASH practices category 0.789
 Good WASH  indexc 55 (59.1) 58 (61.0)
 Poor WASH index 38 (40.9) 37 (39.0)
Wealth quartiles  distributiond n = 88 n = 89 0.806
 First 25 (28.4) 21 (23.6)
 Second 23 (26.1) 27 (30.3)
 Third 19 (21.6) 22 (24.7)
 Fourth 21 (23.9) 19 (21.3)
Page 4 of 7Bahwere et al. BMC Res Notes  (2017) 10:570 
Discussion
Undernutrition in early life is associated with a num-
ber of adverse health consequences, including impaired 
growth and neurocognition, long-term body composition 
abnormalities and persistent immune system dysfunction 
[27–30]. Little is known about how the CMAM approach 
can be improved so that long-term benefits are added 
to the well-documented short-term benefits already 
Table 2 Results of delayed-type hypersensitivity reaction on tuberculin antigen
Proportions are compared using Pearson Chi square or Fisher exact test as appropriate, means are compared using unpaired Student t test. SAM severe acute 
malnutrition, delayed-type hypersensitivity skin reaction considered positive if induration diameter ≥ 10 mm
Skin test categories Baseline Follow-up (6 months) p value
n (%) n (%)
Proportion of anergic
 Post-SAM (n = 93/86) 83 (89.2) 79 (92.0) 0.551
 Community control (n = 94/89) 90 (95.7) 84 (94.4) 0.742
 p value 0.091 0.604
Proportion with any induration
 Post-SAM (n = 93/86) 10 (10.8) 7 (8.0) 0.551
 Community control (n = 94/89) 4 (4.3) 5 (5.6) 0.742
 p value 0.091 0.604
Positive test (induration ≥ 10 mm)
 Post-SAM (n = 93/86) 3 (3.2) 6 (7.0) 0.316
 Community control (n = 94/89) 2 (2.1) 3 (3.4) 0.676
 p value 0.682 0.324
Skin test categories Baseline Follow-up (6 months) p value
Mean ± SD Mean ± SD
Average diameter of induration
 Post-SAM (n = 10/7) 10.2 ± 9.8 14.9 ± 4.4 0.256
 Community control (n = 4/5) 7.7 ± 6.4 11.2 ± 3.5 0.327
 p value 0.648 0.150
Average induration for positive test
 Post-SAM (n = 3/6) 21.7 ± 1.0 15.9 ± 3.9 0.044
 Community control (n = 2/3) 13.0 ± 3.5 13. 7 ± 1.0 0.748
 p value 0.398 0.376
Fig. 1 Diameter of induration at enrolment and follow up for the children exhibiting an induration during at least one assessment time-point. Post-
SAM post-severe acute malnutrition treatment (cases)
Page 5 of 7Bahwere et al. BMC Res Notes  (2017) 10:570 
being achieved. Thus, it is important to start to focus 
on improving our knowledge on the impact of current 
treatment protocols on the quality of immune system 
normalisation as it is clear that cell mediated immu-
nity and resistance to infection are not being adequately 
recovered.
This short report presents our attempts to characterize 
the quality of immune system repair at the time of being 
discharged as recovered from CMAM programmes. Using 
the TST we were not able to confirm whether cell-medi-
ated immunity was adequately or inadequately repaired in 
post-SAM cases as the TST appeared to be inappropriate 
for assessing immune system functioning in our study set-
ting. However, the difference in incidence of symptoms of 
common infectious diseases suggests cases did have low-
ered immunity than controls, since impairment in cellu-
lar mediated immunity is independently associated with 
increased incidence of these diseases [31–33].
Despite the still limited understanding of the interplay 
between the immune function and SAM, existing evi-
dence points toward impairment of cell-mediated immu-
nity during SAM episode including DTHR [34–39]. Also, 
it has been suggested that DTHR return to normal after 
successful treatment of SAM [40]. Thus, we understood 
that checking DTHR using TST was logical to assess the 
immune system recovery in children who were treated 
under the current CMAM programme as virtually all 
children are Bacille Calmette–Guérin (BCG) vaccinated 
in the region and BCG vaccinated children with low risk 
of tuberculosis infection can have a positivity of up to 
80%, as observed in Turkey [41]. Unfortunately, contrary 
to our hypothesis of high prevalence of positive DTHR in 
matched controls, almost all exhibited anergy making it 
difficult to link the impaired DTHR in cases solely to the 
insufficiency of nutrition recovery.
Our results differ from that of an early study con-
ducted in Colombia that showed a rapid increase in TST 
positivity from 0% for kwashiorkor children and 5.5% 
for marasmic children at admission to 50% for kwashi-
orkor children and 90.9% for marasmic children after 
6 weeks of therapeutic feeding [37]. They also differ from 
that of Forse et  al. who showed in 257 adults on pre-
surgical total parenteral nutrition that reduced cell mass 
was associated with impaired DTHR, while nutrition 
recovery and accompanying increased body mass cells 
improved the likeliness of positive DTHR [42]. However, 
our results are in accord with some studies conducted 
in African children that showed negative DTHR even in 
presence of both BCG scar and confirmed active tuber-
culosis pulmonary infections [23, 24, 43, 44]. They are 
also consistent with results of a study among Ethiopian 
adults that reported a lower prevalence of tuberculosis 
infection when using TST than when using T-cell based 
interferon-g release assays [45]. Thus, even if TST may 
be used in certain contexts to assess immune system 
competence, our study suggests it cannot be universally 
recommended for children (whether these are children 
with SAM or those who are apparently well-nourished) 
living in countries with similar characteristics as Ethio-
pia. We tentatively suggest that in rural Ethiopia the high 
frequency of environmental enteric dysfunction and high 
incidence of viral, bacterial and parasitic infection may 
adversely affect the DTHR test, including in non-mal-
nourished children, by maintaining children in a state of 
chronic inflammation [22, 34, 46–48]. Also, despite not 
being wasted, the control group may have undiagnosed 
micronutrient deficiencies that can affect the DTHR [49]. 
These factors may also explain why many of the children 
did not have a BCG scar despite being BCG vaccinated. 
Nonetheless, TST negative results are also common 
among BCG vaccinated children from United Kingdom, 
who are unlikely to have micronutrients deficiencies and 
who are most likely to be immune-competent, suggest-
ing that factors unrelated to immunity contribute to the 
presence of the negative TST [50].
Despite the null TST results the fact that cases had a 
higher reported incidence of common diseases than con-
trols suggests that at time of reaching the anthropometric 
discharge criteria currently recommended by the Ethio-
pian national guidelines for management of SAM, the 
immunity has not completely recovered. This is in accord 
with several previous studies that showed that immune 
recovery measured by thymus size, serum immunoglobu-
lin level or CD4 count is delayed comparatively to anthro-
pometric recovery [51–54]. To date, all these results have 
not yet been considered for defining practical criteria for 
judging recovery that combine body mass catch up and 
immune recovery [20, 55].
In conclusion, this study did not permit a conclusion 
on immune recovery following CMAM treatment for 
SAM, whether at discharge or at 6 months follow up but 
suggests persistence of lower resistance to infection after 
the anthropometric criteria of nutrition recovery are 
reached. Research is needed to identify a clinical proxy of 
immunity recovery that can be used in community-based 
programmes in low income countries.
Limitations
Having a laboratory blood test confirming immunity dis-
turbance could have strengthened our conclusion. Rytter 
et al. have proposed laboratory tests to use in the assess-
ment of immune system recovery, but most of the pro-
posed tests are difficult to conduct in the low income 
settings where most SAM children are found [34]. Future 
research should include the quantification of T cell recep-
tor excision circles using Dried Blood Spot specimens to 
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measure the quantity of circular deoxyribonucleic acid 
molecules formed during rearrangement of the T cell 
receptor genes during lymphocyte development [56–58]. 
The test is increasingly used in screening newborns for 
primary immunodeficiency and for assessing immune 
response to the antiretroviral treatment of HIV infected 
children [59, 60]. The simplicity of the sampling allows 
prospective sampling at several points during manage-
ment and follow-up after discharge and may help validate 
the choice of clinical and anthropometric parameters 
best used as a proxy of immune system recovery.
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